Coronavirus (COVID-19)

The COVID-19 (Coronavirus) pandemic is leading to a rapidly expanding and evolving literature. This evidence collection contains plain-language summaries of high-quality research which are available in English, and translated into French, German, Italian, Spanish, Portuguese, Arabic and Chinese (simplified and traditional). It was first published in March 2020.

The collection includes summaries of systematic reviews that might be relevant to the direct impact of COVID-19 (including reviews of emerging research, as well as existing reviews of relevant interventions) on health and other outcomes, the impact of the COVID-19 response on other conditions, and issues to consider for the recovery period after COVID-19.

It is being put together by our volunteers, and is supported by our partners and funders. Read our disclaimer.

Other agencies are also publishing vital information. View our COVID-19 information portal for external links.

The content in this Evidence Collection is covered by the Creative Commons License: This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms. CC BY-NC-SA includes the following elements:  BY: credit must be given to the creator. NC: Only noncommercial uses of the work are permitted. SA: Adaptations must be shared under the same terms.